• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Michael A. Crump, John Kuruvilla, +20 authors Lois E. Shepherd
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2014 (First Publication: 29 September 2014)
  • PURPOSE For patients with relapsed or refractory aggressive lymphoma, we hypothesized that gemcitabine-based therapy before autologous stem-cell transplantation (ASCT) is as effective as and lessExpand
  • C. Tom Kouroukis, Andrew J. Belch, +8 authors Joseph M. Connors
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2003 (First Publication: 1 May 2003)
  • PURPOSE To determine the response rate and toxicity of flavopiridol in patients with previously untreated or relapsed mantle-cell lymphoma. PATIENTS AND METHODS Adult patients with previouslyExpand
  • Andrew R. Belch, C. Tom Kouroukis, +6 authors Elizabeth A. Eisenhauer
  • Medicine
  • Annals of oncology : official journal of the…
  • 2006 (First Publication: 3 October 2006)
  • BACKGROUND We evaluated the activity and toxic effects of bortezomib in patients with mantle cell lymphoma. PATIENTS AND METHODS Thirty patients, including 29 eligible patients, were enrolled; 13Expand
  • Christine I. Chen, C. Tom Kouroukis, +7 authors Elizabeth Eisenhauer
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2007 (First Publication: 20 April 2007)
  • PURPOSE To evaluate the efficacy and toxicity of single-agent bortezomib in Waldenström's macroglobulinemia (WM). PATIENTS AND METHODS Symptomatic WM patients, untreated or previously treated,Expand
  • Khalid S. Al-Saleh, Ghazi Alotaibi, Hind Almodaimegh, Aamer Aleem, C. Tom Kouroukis
  • Medicine
  • The Journal of arthroplasty
  • 2013 (First Publication: 1 October 2013)
  • Erythropoiesis-stimulating agents (ESAs) have been used in orthopedic patients to reduce allogeneic blood transfusion (ABT). The purpose of this systematic review of randomized clinical trials is toExpand